Versant Capital Management, Inc Kura Oncology, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,236 shares of KURA stock, worth $7,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,236
Previous 964
28.22%
Holding current value
$7,613
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
189Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$47.8 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$45.8 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$42.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$40.5 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$30.5 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $412M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...